KKR vs CME Group
KKR is one of the world's premier alternative asset managers raising and deploying capital across private equity, credit, and real assets at global scale, while CME Group operates the world's largest derivatives exchange and earns fees on every futures and options contract traded. Both firms benefit from financial market complexity and the growing institutional need to manage risk or access alternative returns. The KKR vs CME Group comparison contrasts performance-driven asset management economics with the near-utility-like fee stability of exchange infrastructure.
KKR is one of the world's premier alternative asset managers raising and deploying capital across private equity, credit, and real assets at global scale, while CME Group operates the world's largest ...
Why It's Moving
KKR's Record $129B Fundraising in 2025 Fuels Analyst Optimism for 2026 Growth
- Record fundraising of $129 billion in 2025 nearly doubled 2023 levels, signaling robust investor demand for KKR's diversified asset management platform across multiple investment strategies
- 18% year-over-year management fee growth in Q2 2025 demonstrates surging demand for KKR's services, directly enhancing forward earnings visibility as the firm deploys capital into acquisitions like the $1.4 billion Arctos deal
- Analysts maintain a consensus 'Strong Buy' rating with average price targets around $155-$158, reflecting confidence that accelerated deployment and exit activity could unlock significant value if market conditions remain favorable
CME Stock Faces Analyst Skepticism as Valuation Concerns and Technical Weakness Weigh on Outlook
- Analyst consensus reflects muted sentiment, with average price targets suggesting potential downside from current levels, prompting a wait-and-see stance from major research firms
- Technical indicators display conflicting signals between buy and sell positions, with the stock currently in a consolidation phase that began mid-April, creating uncertainty for short-term traders
- Structural headwinds including unfavorable return on capital, concentration risk, and intense competitive pressures are constraining investor enthusiasm despite the company's market position
KKR's Record $129B Fundraising in 2025 Fuels Analyst Optimism for 2026 Growth
- Record fundraising of $129 billion in 2025 nearly doubled 2023 levels, signaling robust investor demand for KKR's diversified asset management platform across multiple investment strategies
- 18% year-over-year management fee growth in Q2 2025 demonstrates surging demand for KKR's services, directly enhancing forward earnings visibility as the firm deploys capital into acquisitions like the $1.4 billion Arctos deal
- Analysts maintain a consensus 'Strong Buy' rating with average price targets around $155-$158, reflecting confidence that accelerated deployment and exit activity could unlock significant value if market conditions remain favorable
CME Stock Faces Analyst Skepticism as Valuation Concerns and Technical Weakness Weigh on Outlook
- Analyst consensus reflects muted sentiment, with average price targets suggesting potential downside from current levels, prompting a wait-and-see stance from major research firms
- Technical indicators display conflicting signals between buy and sell positions, with the stock currently in a consolidation phase that began mid-April, creating uncertainty for short-term traders
- Structural headwinds including unfavorable return on capital, concentration risk, and intense competitive pressures are constraining investor enthusiasm despite the company's market position
Investment Analysis
KKR
KKR
Pros
- KKR reported strong Q3 2025 earnings, exceeding both EPS and revenue forecasts with robust growth in fee-related earnings.
- The firm achieved record fundraising and expanded its presence in high-growth areas such as private credit and Asian markets.
- KKR's acquisition of OSTTRA enhances its infrastructure and technology offerings, broadening its alternative asset management platform.
Considerations
- Despite strong results, KKR's stock has shown volatility and underperformed in pre-market trading, reflecting investor caution.
- The company trades at a high valuation multiple, which may limit upside and increase sensitivity to market sentiment.
- KKR's earnings are closely tied to fundraising cycles and capital markets activity, making them vulnerable to economic downturns.
CME Group
CME
Pros
- CME Group maintains a dominant position in global derivatives trading, benefiting from high trading volumes and market resilience.
- The company generates stable, recurring revenue from clearing and exchange fees, supporting strong cash flow generation.
- CME Group has a robust balance sheet and a history of returning capital to shareholders through dividends and buybacks.
Considerations
- CME Group's growth is limited by market saturation and regulatory scrutiny in the exchange sector.
- Revenue is sensitive to interest rate changes and macroeconomic conditions, which can impact trading activity.
- The company faces increasing competition from alternative trading platforms and fintech disruptors.
KKR (KKR) Next Earnings Date
KKR's next earnings date is May 5, 2026, ahead of market open, covering the Q1 2026 period ending March 31. This follows their most recent Q4 2025 report on February 5, 2026, aligning with the firm's typical early-month quarterly cadence. Investors should monitor for updates, as dates can shift based on company announcements.
CME Group (CME) Next Earnings Date
CME Group's next earnings date was April 22, 2026, covering the first quarter of 2026 (Q1 2026), released before market open. This followed their prior report on February 4, 2026, for Q4 2025. The subsequent Q2 2026 earnings are typically expected in late July, consistent with historical quarterly patterns.
KKR (KKR) Next Earnings Date
KKR's next earnings date is May 5, 2026, ahead of market open, covering the Q1 2026 period ending March 31. This follows their most recent Q4 2025 report on February 5, 2026, aligning with the firm's typical early-month quarterly cadence. Investors should monitor for updates, as dates can shift based on company announcements.
CME Group (CME) Next Earnings Date
CME Group's next earnings date was April 22, 2026, covering the first quarter of 2026 (Q1 2026), released before market open. This followed their prior report on February 4, 2026, for Q4 2025. The subsequent Q2 2026 earnings are typically expected in late July, consistent with historical quarterly patterns.
Buy KKR or CME in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
